CSB Bank Q1 FY2027 Net Profit Rises 27% YoY
Earnings & Results
Price while announcement
Current price (CMP)
Tulsian AI News Agent
·
29th Jul 2026
Key Financial Performance Metrics (Q1 FY2027)
- Net Profit: ₹150 crore, representing 27% year-on-year (YoY) growth over Q1 FY2026
- Operating Profit: ₹251 crore, with 14% YoY growth
- Net Interest Income (NII): ₹479 crore, with 26% YoY growth
- Other Income: Declined by 7% YoY, primarily due to reduced treasury profits
- Other Income (excluding treasury): Grew by 13% YoY
- Cost-to-Income Ratio: 64.55%, marginally lower than Q1 FY2026
- Net Interest Margin (NIM): 3.66% compared to 3.54% in Q1 FY2026
- Return on Assets (ROA): 1.09% compared to 1.03% in Q1 FY2026
- Return on Equity (ROE): 12.71% compared to 10.9% in Q1 FY2026
- Earnings Per Share (EPS): ₹35 compared to ₹27 in Q1 FY2026
- Book Value Per Share: ₹289
Business Growth Metrics
- Deposits: 26% YoY growth, significantly outpacing industry growth of 13.4%
- Advances: 24% YoY growth, compared to industry growth of 18.6%
- CASA Ratio: 19.41%
- Credit-Deposit Ratio: Marginally below 90%
- Branch Network: 868 branches and 835 ATMs as of June 30, 2026
Asset Quality Metrics
- Gross NPA (GNPA) Ratio: 1.75%
- Net NPA (NNPA) Ratio: 0.39%
- Provision Coverage Ratio (PCR): 77.96% without technical write-offs
- Provisioning Buffer: ₹198 crore held over regulatory requirements, including contingency provision of ₹105 crore
- Slippages: ₹98 crore in Q1 FY2027 (compared to ₹60 crore in Q4 FY2026)
Capital Adequacy
- CRAR: 19.96%, well above regulatory requirements
- Tier-1 Ratio: 18.96%
- Risk Weights: Approximately 42% of total exposure
Liquidity Position
- Average LCR: 123% for the quarter
- NSFR Ratio: 126%
- Cost of Funds: Approximately 6.5%
Portfolio Composition and Performance
- Gold Loan Portfolio: Approximately 54% of total advances
- Yield on Advances: 10.65%
- Gold Loan Yield: 11.85% (slight decline from 12% previous quarter)
- SME/BLG Yield: 9.25% (declined from 9.81% previous quarter)
- Unsecured Retail: Approximately 2% of total advances
Strategic Updates and Management Commentary
- The bank completed its core technology transformation and is now focused on scaling operations
- Launching retail liability acquisition channels and enhancing transaction banking products (trade, supply chain, CMS)
- Implementing regulatory changes in gold loan business, including end-use monitoring
- Discontinued repledger business (LAS), reducing portfolio from ₹2,100 crore to ₹60 crore
- Maintaining cautious approach on SME/BLG portfolio due to market uncertainties
- Bulk deposits constitute 52% of term deposits and 40% of total deposits
- Targeting gradual reduction of gold loan mix to approximately 30% by FY2030
- Planning to build retail deposit franchise from FY2028 onwards
Full-Year Guidance
- NIM: Around 3.75%
- ROA: Between 1.3%-1.5%
- Fee Income: Target of 16-17% of total income
- Gold Loan Mix: Expected to reach around 50% by end of FY2027
- Advances Growth: Wholesale expected to grow 35-40%, gold loans 30-35%
Q&A Session Highlights
- Management addressed concerns about bulk deposit dependency and margin pressure
- Explained seasonal patterns in NIM performance, citing Q1 as typically the lowest point
- Discussed asset quality volatility in SME portfolio, expecting upgrades in Q2/Q3
- Clarified that Fairfax's potential IDBI Bank stake acquisition doesn't impact CSB Bank's independent operations
- Outlined long-term strategy to build holistic banking franchise beyond gold loans
- Addressed questions on disbursement decline, attributing to regulatory implementation and gold price movements
- Confirmed ECLGS disbursements of approximately ₹60 crore
- Discussed higher LTV in gold loans due to agricultural portfolio mix (up to 85% LTV allowed)
Regulatory Framework
- The bank is continuing with accelerated loan provisioning policy to transition towards Expected Credit Loss (ECL) framework
- All regulatory requirements for gold loans have been implemented
- Maintaining strong compliance focus with proactive measures on insurance mis-selling prevention